Press release
August 5, 2026
Twist Bioscience Announces Pricing of Upsized $300.0 Million Public Offering of Common Stock
Twist Bioscience Corp (TWST)
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Aug. 4, 2026-- Twist Bioscience Corporation (Nasdaq: TWST) (“Twist”), a mid-cap growth and value biotech company, today announced the pricing of an upsized underwritten public offering of 3,125,000 shares of its common stock at a price to the public of